Partner Content Partner Content Superbugs: Exclusive Interviews Released with ABAC Therapeut... Q&A's Out Ahead of Superbugs 2018
Partner Content Partner Content Updates on Antibiotic Drug Resistance the medical industry n... New updates on AMR presented at Superbugs USA 2017
News Pharma outlines roadmap as UN takes on superbug fight UN leaders meet amid warnings over drug resistant bacteria.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
